American Regent
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$630Kgeneral payments (2019-2025)
$176Kresearch payments (2019-2025)
626clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Mahmoud Loghman-Adham | Nutley, NJ | Pediatric Nephrology | $155,464.12 |
| Lawrence Goodnough | Stanford, CA | Internal Medicine | $33,408.23 |
| Michael Levine | Philadelphia, PA | Pediatric Endocrinology | $30,119.05 |
| Sathyaprasad Burjonrappa | New Brunswick, NJ | Pediatric Surgery | $21,658.86 |
| Muthiah Vaduganathan | Boston, MA | Cardiovascular Disease | $20,844.28 |
| Malcolm Munro | Los Angeles, CA | Obstetrics & Gynecology | $20,163.75 |
| Stanley Goldfarb | Philadelphia, PA | Nephrology (Internal Medicine) | $17,810.00 |
| Melvin Seid | Mauldin, SC | Obstetrics & Gynecology | $16,017.84 |
| Steven Fein | Miami, FL | Hematology & Oncology | $15,198.61 |
| Satheesh Kathula | Kettering, OH | Hematology & Oncology | $14,872.60 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.